Cargando…
Severe Primary Raynaud's Disease Treated with Rituximab
Raynaud's phenomenon refers to reversible spasms of the peripheral arterioles that can be primary Raynaud's phenomenon (PRP) or secondary Raynaud's phenomenon (SRP) to underlying connective tissue disease, both of which are characterized by a triphasic color response triggered by cold...
Autores principales: | Shabrawishi, Mohammed, Albeity, Abdurahman, Almoallim, Hani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019931/ https://www.ncbi.nlm.nih.gov/pubmed/27651971 http://dx.doi.org/10.1155/2016/2053804 |
Ejemplares similares
-
A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
por: Awad, Neveen, et al.
Publicado: (2016) -
Dermatomyositis Flare After a COVID-19 Infection Successfully Treated with Rituximab: A Case Report and Literature Review
por: Albakri, Ahmed Mohammed, et al.
Publicado: (2022) -
Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch–Schönlein purpura, ankylosing spondylitis, and Raynaud’s phenomenon
por: Taha, Rbab, et al.
Publicado: (2017) -
Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab
por: Tjensvoll, Anne Bolette, et al.
Publicado: (2019) -
A serious case of primary Raynaud's phenomenon in an infant
por: Kobayashi, Masaru, et al.
Publicado: (2018)